文献

J-GLOBAL ID：202102272217505281   整理番号：21A1667691

S-1誘導円板状エリテマトーデス様病変と膵管腺癌の傍大動脈リンパ節再発に対する長期完全寛解:症例報告

S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report

著者 (7件)： Yamaga Ryosuke (First Department of Surgery, Graduate School of Medical Science, Yamagata University, Yamagata, Japan) ,  Tezuka Koji (First Department of Surgery, Graduate School of Medical Science, Yamagata University, Yamagata, Japan) ,  Sugawara Shuichiro (First Department of Surgery, Graduate School of Medical Science, Yamagata University, Yamagata, Japan) ,  Watanabe Toshihiro (First Department of Surgery, Graduate School of Medical Science, Yamagata University, Yamagata, Japan) ,  Hirai Ichiro (First Department of Surgery, Graduate School of Medical Science, Yamagata University, Yamagata, Japan) ,  Suzuki Tamio (Department of Dermatology, Graduate School of Medical Science, Yamagata University, Yamagata, Japan) ,  Kimura Wataru (First Department of Surgery, Graduate School of Medical Science, Yamagata University, Yamagata, Japan)
資料名： Surgical Case Reports (Web)  (Surgical Case Reports (Web))
巻： 4  号： 1  ページ： 1-6  発行年： 2018年 
JST資料番号： U1015A  ISSN： 2198-7793  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 膵癌切除後の転移再発は難治性疾患と考えられ,円板状エリテマト...

シソーラス用語： ヒト ,...
準シソーラス用語： アジュバント化学療法 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A1667691&from=J-GLOBAL&jstjournalNo=U1015A") }}

分類 (2件)： 消化器の腫よう  (GH04000D) ,  腫ようの薬物療法  (GE03032C)

物質索引 (2件)： S-1 ,  ゲムシタビン

引用文献 (24件)：

• Anti-Cancer Drugs; Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators; T Shirasaka, Y Shimamato, H Ohshimo, M Yamaguchi, T Kato, K Yonekura; 7; 1996; 548-557; 10.1097/00001813-199607000-00010; citation_id=CR1
• Ann Surg; A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy; W Kimura, H Miyata, M Gotoh, I Hirai, A Kenjo, Y Kitagawa; 259; 2014; 773-780; 10.1097/SLA.0000000000000263; citation_id=CR2
• Lancet; Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01); K Uesaka, N Boku, A Fukutomi, Y Okamura, M Konishi, I Matsumoto; 388; 2016; 248-257; 10.1016/S0140-6736(16)30583-9; citation_id=CR3
• Jpn J Clin Oncol; S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure; A Todaka, A Fukutomi, N Boku, Y Onozawa, S Hironaka, H Yasui; 40; 2010; 567-572; 10.1093/jjco/hyq005; citation_id=CR4
• Cancer Chemother Pharmacol; A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer; C Morizane, T Okusaka, J Furuse, H Ishii, H Ueno, M Ikeda; 63; 2009; 313-319; 10.1007/s00280-008-0741-7; citation_id=CR5

タイトルに関連する用語 (10件)： S-1 ,  誘導 ,  円板状エリテマトーデス ,  病変 ,  膵管腺癌 ,  傍大動脈リンパ節 ,  再発 ,  長期 ,  完全寛解 ,  症例報告